Assessing Quality and Functionality of DNA from Fresh and Archival Dried Blood Spots and Recommendations for Quality Control Guidelines
- 1 August 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 53 (8) , 1401-1407
- https://doi.org/10.1373/clinchem.2007.087510
Abstract
Background: Dried blood spots (DBS) are a convenient and inexpensive method for biobanking. Although many countries have established population-based DBS biobanks from neonatal screening programs, the quality and usefulness of DNA from DBS have not been extensively assessed. Methods: We compared 4 common DNA extraction methods (Qiagen, EZNA, Chelex 100, and alkaline lysis) in a pilot study using fresh DBS with known lymphocyte count. We assessed suitability for multiple displacement amplification (MDA) and subsequent single-nucleotide polymorphism (SNP) analyses. We selected the EZNA method for DNA extraction from archival samples up to 27 years old, stored at room temperature or −20 °C, and SNP analyses were performed after MDA. Results: Extraction using alkaline lysis failed in most tests, and Chelex 100 was unsuccessful in real-time PCR, whereas the EZNA and Qiagen methods were successful by all evaluated quality indices. DNA extraction by EZNA, MDA, and SNP analyses were successful for the archival samples stored at −20 °C. Conclusion: Routine protocols for evaluation of the quality and functional integrity of DNA based on DNA yield, DNA size, and quantification of amplifiable DNA allow use of sufficient template for MDA and successful SNP analyses from both primary DBS extract and MDA product. A single 3-mm disc can yield sufficient DNA for several thousand SNP analyses. DNA from DBS is thus suitable for genetic epidemiology studies.Keywords
Funding Information
- Swedish National Biobanking Program
- Knut and Alice Wallenberg Foundation
- Cancer Control Using Population-Based Registries and Biobanks
This publication has 13 references indexed in Scilit:
- Should donors be allowed to give broad consent to future biobank research?The Lancet Oncology, 2006
- Comparing Whole-Genome Amplification Methods and Sources of Biological Samples for Single-Nucleotide Polymorphism GenotypingClinical Chemistry, 2005
- Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studiesNucleic Acids Research, 2005
- Microarray-based Detection of Mannose-binding Lectin 2 (MBL2) Polymorphisms in a Routine Clinical SettingGenetic Testing, 2005
- A high throughput β-globin genotyping method by multiplexed melting temperature analysisMolecular Genetics and Metabolism, 2004
- Whole Genome Analysis of Genetic Alterations in Small DNA Samples Using Hyperbranched Strand Displacement Amplification and Array–CGHGenome Research, 2003
- Universal Newborn Screening for Hb H Disease in CaliforniaGenetic Testing, 2001
- Genetic polymorphism of alcohol dehydrogenase in europeans: The ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1Hepatology, 2000
- Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal HyperplasiaJournal of Clinical Endocrinology & Metabolism, 1999
- Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNAProceedings of the National Academy of Sciences, 1996